PM-004

N/A

Report date: 2023/01/14 15:50:54

Base Information

Drug NamePM-004
Drug Alias NamePM-004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsImmune System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPhoremost Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPhoremost Ltd
Inactive CompaniesN/A
Active IndicationsImmune System DiseasesNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A